| DEVELOPMENT |
Cynthia A. Challener
FDA’s approval rate slowed, but the US agency is still ahead of its international counterparts in green-lighting new drugs for market.
read more
Felicity Thomas
Biologics raise unique formulation and development challenges, and industry is still on a learning curve to get the best out of these diverse and complex therapies.
read more
| MANUFACTURING |
Jennifer Markarian
Data collected through the Industrial Internet of Things enable predictive maintenance.
read more
Caroline McCormack, Chris O’Callaghan, Gareth Clarke, Ian Jones, Luke Kiernan, Gavin Walker
Advanced dynamic process control of a fluid-bed granulation process using PAT data improves product quality.
read more
| PEER-REVIEWED RESEARCH |
Gayatri C. Patel
The aim of this study was to prepare taste-masked drug-resin complex using ion exchange resin Kyron T-134.
read more
| Quality/Regulations |
James Agalloco
Past mistakes and misstatements have adversely influenced industry decontamination practices with vapor phase hydrogen peroxide, and this article endeavors to clarify the process.
read more
Agnes Shanley
Focusing on symptoms instead of root causes locks teams into a corrective, rather than preventive, mindset.
read more
| OPERATIONS |
Hallie Forcinio
Pharmaceutical companies work toward a circular economy by using sustainable packaging.
read more
| FROM THE EDITOR |
Rita C. Peters
The promise of new therapies is tempered by the need for affordability, safety, and ethics.
read more
| US REGULATORY WATCH |
Jill Wechsler
Pressures on FDA will affect industry’s success in bringing new therapies to market.
read more
|
On Demand
On Demand